Prevention of polyglutamine oligomerization and neurodegeneration by the peptide inhibitor QBP1 in Drosophila.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Prevention of polyglutamine oligomerization and neurodegeneration by the peptide inhibitor QBP1 in Drosophila.
- Published In:
- Human molecular genetics, 12(11), 1253-9 (2003)
- Authors:
- Nagai, Yoshitaka, Fujikake, Nobuhiro, Ohno, Katsuhito, Higashiyama, Hiroyuki, Popiel, Helena A, Rahadian, Julia, Yamaguchi, Masamitsu, Strittmatter, Warren J, Burke, James R, Toda, Tatsushi
- Database ID:
- RPEP-00850
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-00850APA
Nagai, Yoshitaka; Fujikake, Nobuhiro; Ohno, Katsuhito; Higashiyama, Hiroyuki; Popiel, Helena A; Rahadian, Julia; Yamaguchi, Masamitsu; Strittmatter, Warren J; Burke, James R; Toda, Tatsushi. (2003). Prevention of polyglutamine oligomerization and neurodegeneration by the peptide inhibitor QBP1 in Drosophila.. Human molecular genetics, 12(11), 1253-9.
MLA
Nagai, Yoshitaka, et al. "Prevention of polyglutamine oligomerization and neurodegeneration by the peptide inhibitor QBP1 in Drosophila.." Human molecular genetics, 2003.
RethinkPeptides
RethinkPeptides Research Database. "Prevention of polyglutamine oligomerization and neurodegener..." RPEP-00850. Retrieved from https://rethinkpeptides.com/research/nagai-2003-prevention-of-polyglutamine-oligomerization
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.